2 interesting points from the call that did not get as much attention
1. IND for MS - that is a total new area - obviously it is a long journey
2. The virus in blood - Dr BP highlighted this point few times. He also repeated that virus in plasma is better way to test CV than swab.
I was more excited about it as the so many companies are going towards different testing methods. A blood based testing may be easier and more effective.
Great post! It is so good to see that the mass media is showing some skepticism of this ‘standard of care!’ The more that the manipulation of this whole review of Remdesivir is made public, the more you can call the procedure flawed and the better chance that Leronlimab will get an objective review.